MJR PharmJet GmbH

nTRACK Horizon 2020

6,8€ Million Granted to nTRACK Horizon 2020 Project Designed to Study Multimodal Nanoparticles for Muscle Regeneration

Grant from European Union’s Horizon 2020 programme to nTRACK project designed to study multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regeneration

The European Union has awarded a grant of 6,8 million Euro to nTRACK collaborative project. The grant, from the Horizon 2020 framework programme, was awarded to nTRACK, a research and innovation project carried out by an international consortium led by LEITAT. The project partners are: MJR PharmJet, Bar Ilan University, Pluristem Therapeutics, University of Mainz, BET Solutions, National Centre for Scientific Research “Demokritos”, Vall d'Hebron Research Institute, Vivotecnia Research, RIVM, Asphalion, and Cambridge Nanomaterials Technology. The project will officially be launched on the 16th of October in Barcelona.

Press release nTrack Horizon 2020 Project